aTyr Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2016 | $-52.9M | $-53.5M | $600.0K |
| FY2017 | $-42.4M | $-43.7M | $1.3M |
| FY2018 | $-31.1M | $-31.7M | $594.0K |
| FY2019 | $-20.0M | $-20.1M | $79.0K |
| FY2020 | $-15.3M | $-15.5M | $202.0K |
| FY2021 | $-33.1M | $-33.3M | $192.0K |
| FY2022 | $-41.9M | $-43.5M | $1.6M |
| FY2023 | $-33.2M | $-37.4M | $4.2M |
| FY2024 | $-69.1M | $-69.2M | $65.0K |
| FY2025 | $-62.0M | $-62.1M | $77.0K |